comparemela.com
Home
Live Updates
Neal Shore - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Neal shore - Page 1 : comparemela.com
Pluvicto May Slow Progression Earlier in Advanced Prostate Cancer
Treatment with Pluvicto following ARPI resulted in favorable progression and response outcomes in PSMA-positive mCRPR.
Boston
Massachusetts
United-states
Dana-farber-cancer-institute
American
Xiaox-wei
Drug-administration
American-urological-association-annual-meeting
Carolina-urologic-research-center
Neal-shore
Erleada, ADT 'One-Two Punch' in Prostate Cancer Treatment
The postsurgical combination of androgen deprivation therapy and Erleada has shown promising results in prostate cancer.
United-states
American
Carolina-urologic-research-center
National-cancer-institute
American-urological-association-annual-meeting
Drug-administration
National-cancer
Urological-association-annual-meeting
Neal-shore
Carolina-urologic-research
J&J: encouraging results in prostate cancer
Johnson & Johnson has announced results from an open-label Phase 2 study evaluating adjuvant treatment with Erleada and androgen deprivation therapy in patients with HRLPC who have undergone.
Johnson
Neal-shore
Chief-medical-officer
Surgical-oncology
Markets
Dr Shore on the Importance of a Multidisciplinary Team in Urologic Oncology
Neal Shore, MD, FACS, discusses the importance of a multidisciplinary team in light of recent developments in urologic oncology.
Carolina-urologic-research-center
Neal-shore
Medical-officer
Genesiscare-united-states
Atlantic-urology-clinics
Bacillus-calmette
Urothelial-cancer
Pemrbolizumab
Multidisciplinary-care
Nivolumab
Enfortumab-vedotin-ejfv-padcev-
Dr Shore on Key Clinical Trial Data in Biochemically Recurrent Prostate Cancer
Neal Shore, MD, FACS, discusses findings from clinical trials in patients with prostate cancer who experience biochemical recurrence.
Carolina-urologic-research-center
Neal-shore
Medical-officer
Genesiscare-united-states
Atlantic-urology
Uspcc
D
Pacs
Biochemical-recurrence
Prostate-cancer
Phase-3-embark-trial-nct02319837
vimarsana © 2020. All Rights Reserved.